Key facts
- This page summarizes Patrick J. Mahaffy's Form 3 filing for Medicus Pharma Ltd. (MDCX).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Sep 2025, 16:36.
Patrick J. Mahaffy - 29 Aug 2025 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)
- Reporting relationship
- Director
- Issuer ticker
- MDCX
- Reported as of
- 29 Aug 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 08 Sep 2025, 16:36:44 UTC
- Prior SEC filing
- 03 Mar 2022
- Next SEC filing
- 18 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Raza Bokhari, as Attorney-in-Fact, for Patrick J. Mahaffy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick J. Mahaffy filed Form 3 for Medicus Pharma Ltd. (MDCX) on 08 Sep 2025.
Change
- Previous filing in this sequence was filed on 03 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001266569
Primary reporting owner
MAHAFFY PATRICK J
- Relationship
- Director
- Address
- 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W. CONSHOHOCKEN
- Signature
- /s/ Raza Bokhari, as Attorney-in-Fact, for Patrick J. Mahaffy
- Signature date
- 08 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDCX
holding
Common Shares, no par value ("Common Shares")
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 35,435
- Date
- 29 Aug 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDCX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 29 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 25,000
- Exercise price
- $1.94
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option is scheduled to vest in equal quarterly instalments over the twelve months immediately following August 29, 2025.
SEC remarks
Exhibit List - Exhibit 24.1 - Power of Attorney